Impact of CYP2C19 metaboliser status on SSRI response: a retrospective study of 9500 participants of the Australian Genetics of Depression Study.
Pharmacogenomics J
; 22(2): 130-135, 2022 03.
Article
in En
| MEDLINE
| ID: mdl-35094016
Full text:
1
Database:
MEDLINE
Main subject:
Selective Serotonin Reuptake Inhibitors
/
Depression
Type of study:
Guideline
/
Observational_studies
/
Risk_factors_studies
Limits:
Adult
/
Humans
Country/Region as subject:
Oceania
Language:
En
Journal:
Pharmacogenomics J
Journal subject:
BIOLOGIA MOLECULAR
/
FARMACOLOGIA
Year:
2022
Type:
Article
Affiliation country:
Australia